Compare GRANULES INDIA with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA SUN PHARMA GRANULES INDIA/
SUN PHARMA
 
P/E (TTM) x 16.0 32.1 50.0% View Chart
P/BV x 3.5 4.3 81.9% View Chart
Dividend Yield % 0.5 0.9 54.5%  

Financials

 GRANULES INDIA   SUN PHARMA
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
SUN PHARMA
Mar-21
GRANULES INDIA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs438654 67.0%   
Low Rs138339 40.8%   
Sales per share (Unadj.) Rs130.7139.6 93.6%  
Earnings per share (Unadj.) Rs22.29.5 233.0%  
Cash flow per share (Unadj.) Rs28.318.2 155.6%  
Dividends per share (Unadj.) Rs1.507.50 20.0%  
Avg Dividend yield %0.51.5 34.5%  
Book value per share (Unadj.) Rs86.8193.6 44.8%  
Shares outstanding (eoy) m247.672,399.34 10.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.23.6 62.0%   
Avg P/E ratio x13.052.1 24.9%  
P/CF ratio (eoy) x10.227.3 37.3%  
Price / Book Value ratio x3.32.6 129.4%  
Dividend payout %6.878.8 8.6%   
Avg Mkt Cap Rs m71,3371,190,430 6.0%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24368,622 4.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,375334,981 9.7%  
Other income Rs m2698,592 3.1%   
Total revenues Rs m32,644343,573 9.5%   
Gross profit Rs m8,55241,616 20.6%  
Depreciation Rs m1,51520,800 7.3%   
Interest Rs m2631,414 18.6%   
Profit before tax Rs m7,04427,994 25.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5495,147 30.1%   
Profit after tax Rs m5,49522,847 24.0%  
Gross profit margin %26.412.4 212.6%  
Effective tax rate %22.018.4 119.6%   
Net profit margin %17.06.8 248.8%  
BALANCE SHEET DATA
Current assets Rs m19,970304,421 6.6%   
Current liabilities Rs m11,731161,456 7.3%   
Net working cap to sales %25.442.7 59.6%  
Current ratio x1.71.9 90.3%  
Inventory Days Days16149 10.9%  
Debtors Days Days86399 874.0%  
Net fixed assets Rs m17,157336,682 5.1%   
Share capital Rs m2482,399 10.3%   
"Free" reserves Rs m21,262462,229 4.6%   
Net worth Rs m21,510464,628 4.6%   
Long term debt Rs m3,4118,981 38.0%   
Total assets Rs m37,127641,103 5.8%  
Interest coverage x27.820.8 133.7%   
Debt to equity ratio x0.20 820.5%  
Sales to assets ratio x0.90.5 166.9%   
Return on assets %15.53.8 409.8%  
Return on equity %25.54.9 519.5%  
Return on capital %29.36.2 472.2%  
Exports to sales %81.90-   
Imports to sales %26.80-   
Exports (fob) Rs m26,528NA-   
Imports (cif) Rs m8,691NA-   
Fx inflow Rs m26,52884,493 31.4%   
Fx outflow Rs m8,69130,334 28.6%   
Net fx Rs m17,83754,159 32.9%   
CASH FLOW
From Operations Rs m4,32561,704 7.0%  
From Investments Rs m-2,7715,362 -51.7%  
From Financial Activity Rs m-2,993-59,805 5.0%  
Net Cashflow Rs m-1,4415,964 -24.2%  

Share Holding

Indian Promoters % 41.6 54.5 76.4%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 25.7 34.0 75.7%  
FIIs % 21.4 13.0 164.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 45.5 127.5%  
Shareholders   216,385 680,800 31.8%  
Pledged promoter(s) holding % 7.0 4.8 145.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    CADILA HEALTHCARE    



Today's Market

Sensex Zooms 750 Points as IT & Realty Stocks Rally; M&M, ONGC and NTPC Surge 4%(10:30 am)

Asian stock markets recovered some of the losses today sparked by the Federal Reserve's pivot to tighter monetary policy.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022(Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Jan 28, 2022 01:15 PM

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 8-QTR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS